- FDA reviewers support efficacy of Forest Labs' IV antimicrobial ceftaroline for treating pneumonia, complicated skin and skin structure infections
- FDA updates label for Pfizer's Tygacil to warn of increased mortality risk
- FDA approves Abbott's HBV molecular diagnostic for measuring viral load
- FDA approves new version of Allergan's Lumigan
- FDA approves Reckitt Benckiser's Suboxone sublingual film for treatment of opioid dependence
- Private FFS MA plans may be linked with higher costs for beneficiaries, GAO report shows
- Pediatric subspecialty telephone consultations may be cost-saving for Medicaid, research reveals
- Use of mental health services greater in health plans with parity in cost sharing, data find
- Public opinions appear split on health care affordability, satisfaction, survey finds
- In Brief: California Supreme Court
Home :: Nephrology :: Nephrology Conferences
American Society of Nephrology 2008 Renal Week
November 4 - 9, 2008 Philadelphia, PA- Kidney transplantation may improve cognitive function among patients with ESRD
- Coronary artery bypass surgery may provide improved long-term survival among patients with end-stage renal disease requiring revascularization procedure
- Low potassium level associated with high blood pressure, despite salt intake, CV risk factors
- Kidney stones increase risk of chronic kidney disease, may increase risk of end-stage renal disease in general population, researchers report
- Risk of ESRD in black patients with hypertensive nephrosclerosis exceeds that of CV events, unlike in other CKD populations, data suggest
- Low potassium level associated with high blood pressure, despite salt intake, CV risk factors
- Lipid-modifying drugs may decrease all-cause, cardiovascular-specific mortality in patients on peritoneal dialysis, study data suggest
- Drugs that lower BP reduce cardiovascular morbidity, mortality in patients undergoing dialysis, meta-analysis finds
- Lanthanum appears to reduce serum phosphorus more than sevelamer in patients with CKD, study suggests
- No antibiotic regimen superior in treatment of peritoneal dialysis-associated peritonitis; urokinase, peritoneal lavage ineffective, research shows
- Lipid-modifying drugs may decrease all-cause, cardiovascular-specific mortality in patients on peritoneal dialysis, study data suggest
- No antibiotic regimen superior in treatment of peritoneal dialysis-associated peritonitis; urokinase, peritoneal lavage ineffective, research shows
- Frailty common among patients on dialysis, associated with adverse outcomes, researchers find
- Discontinuation of EPO better than dose reduction among patients on dialysis who exceed hemoglobin targets, study data suggest
- Overall prevalence of CKD increasing with higher rates of diabetes, hypertension, study data show
